Related Experiment Video

Updated: Jul 23, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.6K

[Early to Long-term Results of Left Atrial Appendage Closure Using Clip Device in Patients with Atrial Fibrillation]

Hidetomi Takahashi1, Akihiro Yoshimoto, Yoshiki Yamasaki

  • 1Department of Cardiovascular Surgery, Tsukuba Memorial Hospital, Tsukuba, Japan.

Kyobu Geka. the Japanese Journal of Thoracic Surgery
|March 9, 2024
PubMed

Insights

Oral anticoagulants pose risks for atrial fibrillation patients. Left atrial appendage closure (LAAO) using the AtriClip device shows promising early and long-term results for stroke prevention, warranting further study.

Area of Science:

  • Cardiology
  • Medical Devices
  • Stroke Prevention

Context:

  • Atrial fibrillation necessitates stroke prevention strategies.
  • Oral anticoagulants carry risks like recurrent stroke and bleeding.
  • Surgical options include left atrial appendage closure (LAAO) and resection (LAAR).

Purpose:

  • To evaluate the early and long-term outcomes of AtriClip-based LAAO.
  • To assess AtriClip as an alternative stroke prevention method for atrial fibrillation patients.

Summary:

  • The study investigated left atrial appendage closure (LAAO) using the AtriClip device in patients with atrial fibrillation.
  • Early and long-term results demonstrated stable outcomes with AtriClip.
  • AtriClip may be a viable option for stroke prevention in atrial fibrillation.

Impact:

  • Suggests AtriClip as a potential alternative to oral anticoagulants for stroke prevention in atrial fibrillation.
  • Highlights the need for continued research into LAAO efficacy and safety.
  • Provides data on the clinical performance of a specific LAAO device.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

3.7K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...